Hallkvist O, Johansson J, Nordstrom A, Nordstrom P, Hult A
Arch Osteoporos. 2018; 13(1):9.
PMID: 29380156
PMC: 6310713.
DOI: 10.1007/s11657-018-0420-1.
Lipkowitz S, Kohn E
J Clin Oncol. 2015; 33(35):4127-8.
PMID: 26438113
PMC: 7444335.
DOI: 10.1200/JCO.2015.63.6670.
Josse R
Can Fam Physician. 2011; 29:2113-8.
PMID: 21283471
PMC: 2154301.
Hay J
Can Fam Physician. 2011; 30:270-1.
PMID: 21279007
PMC: 2154044.
Evers S, Myers A
Can Fam Physician. 2011; 33:151-5.
PMID: 21267348
PMC: 2218284.
Salmon calcitonin nasal spray : An effective alternative to estrogen therapy in select postmenopausal women.
Avioli L
Endocrine. 2010; 5(2):115-27.
PMID: 21153101
DOI: 10.1007/BF02738696.
Identifying postmenopausal patients at risk of significant bone loss.
Orchard J, Evers S, Haddad R
Can Fam Physician. 2010; 30:2503-8.
PMID: 20469419
PMC: 2154269.
The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women.
Nordin B
Osteoporos Int. 2009; 20(12):2135-43.
PMID: 19459026
DOI: 10.1007/s00198-009-0926-x.
Physical activity in the prevention and amelioration of osteoporosis in women : interaction of mechanical, hormonal and dietary factors.
Borer K
Sports Med. 2005; 35(9):779-830.
PMID: 16138787
DOI: 10.2165/00007256-200535090-00004.
Hormones and bone health in postmenopausal women.
Lindsay R
Endocrine. 2004; 24(3):223-30.
PMID: 15542889
DOI: 10.1385/ENDO:24:3:223.
Predicting the effects of estrogen replacement therapy on lumbar bone mineral density in oophorectomized women: analysis of a 10-year longitudinal study.
Nagata H, Nozaki M, Nakano H
Osteoporos Int. 2003; 14(11):905-12.
PMID: 14534773
DOI: 10.1007/s00198-003-1447-7.
Population screening for osteoporosis to prevent fractures.
Sheldon T, Freemantle N, Ibbotson S, Pollock C, Mason J, Long A
Qual Health Care. 1992; 1(1):77-80.
PMID: 10136838
PMC: 1056814.
DOI: 10.1136/qshc.1.1.77.
The calcium controversy.
Nordin B
Osteoporos Int. 1997; 7 Suppl 3:S17-23.
PMID: 9536297
DOI: 10.1007/BF03194337.
Use of estrogen for prevention and treatment of osteoporosis.
Marcus R
Endocrine. 1997; 6(2):207-11.
PMID: 9225138
DOI: 10.1007/BF02738967.
Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
CMAJ. 1996; 155(8):1113-33.
PMID: 8873639
PMC: 1335371.
Influence of ovariectomy on bone metabolism in very old rats.
Gaumet N, Seibel M, Braillon P, Giry J, Lebecque P, Davicco M
Calcif Tissue Int. 1996; 58(4):256-62.
PMID: 8661957
DOI: 10.1007/BF02508645.
That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention.
Palferman T
Ann Rheum Dis. 1993; 52(1):74-80.
PMID: 8427521
PMC: 1004962.
DOI: 10.1136/ard.52.1.74.
A clinical trial on the effects of a combination of elcatonin (carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal women.
Meschia M, Brincat M, Barbacini P, Crossignani P, Albisetti W
Calcif Tissue Int. 1993; 53(1):17-20.
PMID: 8394192
DOI: 10.1007/BF01352009.
Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease.
Clements D, Compston J, Evans W, Rhodes J
Gut. 1993; 34(11):1543-6.
PMID: 8244141
PMC: 1374419.
DOI: 10.1136/gut.34.11.1543.
A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis.
Hasling C, Charles P, Jensen F, Mosekilde L
Osteoporos Int. 1994; 4(4):191-203.
PMID: 7949749
DOI: 10.1007/BF01623239.
